Walser Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
1,244
-18
-1% -$18.4K 0.62% 36
2026
Q1
$1.16M Buy
1,262
+23
+2% +$23.3K 0.52% 32
2025
Q4
$1.33M Buy
+1,239
New +$1.18M 0.7% 19

Other funds holding LLY

Walser Wealth Management's LLY Position: Q2 2026 in Review

Walser Wealth Management reduced its Eli Lilly (LLY) stake by 1.4% in Q2 2026, selling an estimated $18.4K and leaving 1,244 shares worth $1.49M. The position accounts for 0.62% of the portfolio, ranked #36.

Walser Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Walser Wealth Management held 1,244 shares of Eli Lilly worth $1.49M as of Q2 2026.
  • Walser Wealth Management sold 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
  • Eli Lilly made up 0.62% of Walser Wealth Management's portfolio in Q2 2026, its #36 holding.
  • Walser Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Walser Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.